Generic Name
Therapeu c
Class
Trade Name
Pharmacologic
Class
An lipemics
Atorvasta n
Lipitor
HMG-CoA
Reductase
inhibitors
Furosemide
diure cs
Lasix
Loop diure cs
Heparin
an coagulants
Hep-Lock
Isosorbide Mononitrate
an thrombo cs
An aginal
Imdur
Nitrate
Tamsulosin
BPH Drugs
Flomax
Metoprolol Tartrate
Safe Dose
Range
Onset
Peak
Dura on
Admin
Time(s)
Mechanism of Ac on
Commons Adverse
Effects
Nursing Considera ons
All reasons for med
O:
Unknown
D: 20mg R: PO
10-80mg daily
P:1-2hr
F: q24
D:Unkno
wn
0900
Inhibits HMG-CoA
reductase, an early step
in cholesterol
biosynthesis
Insonmia, stroke,
rhabdomyolysis, muscle
spasms
Pt should try diet
interven on first, watch
for myopathy
CAD, stroke preven on,
hyperlipidemia
2.5g
D: 40mg R: PO
F:q24
O: 20-60
P1-2hr
D:6-8hr
0900
Inhibits NA & CI
reabsorp on from loop
of Henle & distaltubule
Loss of electrolytes,
dehydra on, headache,
dizziness, SJS
Monitor weight, BP, &
pulse rou nely with
long-term use
Edema, HTN
20000
units/12 hours
SQ
D: 5000 units
R: SQ F: q24
O: Imme
P: Imme
D:
Variable
1300
Poten ates the inhibitory
effect of an thrombin on
factor Xa & thrombin
Excessive bleeding,
thrombocytopenia,
anemia, rash
Monitor platelets count
every 3-4 days during
therapy
DVT or PE.
Thromboprophylaxis
Thought to reduce
cardiac oxygen Demand
by decreasing preload
and a erload drug Also
may increase blood flow
through the collateral
l
receptors in the prostate,
Headache dizziness
orthosta c hypotension
tachycardia nausea
vomi ng
Monitor blood pressure
heart rate intensity and
dura on of drug
response
Angina
Monitor for decrease in
BP
BPH
Hold for BP < 90 HR < 60
HTN MI Angina HF
Max dose is
160mg
D: 30mg R:PO
F: q24
O:30-45
min P:
30-60min
D:4-8hr
0900
max 0.8mg
O:
D: 0.8mg R:PO Unknown
F: q24
P: 4-7hr
D: 9-15hr
0900
Alpha Blockers
an hypertensive
Ordered Dose /
Route / Freq.
400mg ER or
D: 150mg R:
O: 15min
P: 1 hr
0900
leading to relaxa on of
Dizzy, headache, chest
smooth muscles in the pain, ortho hypotension,
bladder neck and
nausea, diarrhea, back
prostate, improving urine
pain
flow and reducing
Selec ve beta-blocker.
Blocks beta1 receptors,
decreases cardia output
Bradycardia, HF, stroke,
fa gue dizziness
Lopressor
Beta-blockers
Spironolactone
diure cs
Aldactone
Potassium Sparing
diure cs
Levothyroxine
Thyroid hormone
replacement
Levoxyl
Acetylsalicylic Acid
thyroid Hormones
g
450mg IR
g
PO F: q12
75mg daily
D: 17.5mg R:
PO F: q24
O:Unkno
wn P:
3-4hr D:
2-3days
D: 50mcg R:
PO F:q24
O:3-5
days P:
2-4 hr D:
Unknown
12.5-25 mcg
start increase
PRN
P: 1 hr
D: 6-12hr
decreases cardia output,
peripheral resistance &
cardia O2 consump on
fa gue, dizziness,
headache, hypotension
Hold for BP < 90, HR < 60
HTN, MI, Angina, HF
0900
Antagonizes aldosterone
in the distal tubules,
increasing sodium and
water excre on
Hyperkalemia,
anaphylaxis,
thrombocytopenia,
headache
Increases serum K levels,
monitor electrolytes,
may effect digoxin level
test
Edema, HTN, HF
0800
Synthe c form of
thyroxine that affects the
growth of ssues, energy
expenditure, and the
turnover of all substrates
Insomnia, headache,
arrhythmias, cardiac
arrest, HF, MI, diarrhea
DM II may need
increased insulin doses
when first started on
med, watch for angina
and CAD
Hypothyroidism,
Myxedema Coma,
Thyroid hormone
replacement
GI bleeding,
hyperglycemia, nasea,
vomi ng, prolonged
bleeding, hepa s,
arrhythmias
Inflammatory condi on,
rheuma c fever, and
thrombosis. Give on
schedule rather than
PRN, monitor elderly as
they're more suscep ble
to toxic effect
MI, Stroke, Mild pain,
Fever, RA, CABG, DVT
preven on
HF, ortho hypo, muscle
spasms
Parkinsons, Drug
May worsen psych
induced extrepyramidal
disorders or drug abuse.
symptoms, Influenze
monitor renal func on
type A virus
2100
NSAID
4000mg
Bayer Aspirin
Salicylates
Amantadine
An virals
Osmolex
Synthe c cyclic
primary amines
Lorazepam
Anxioly cs
A van
Benzodiazepines
O:5-30mi
D: 81mg R: PO
n P:
F: Q12
1-2hr D:
1-4hr
MAX daily
322mg
D: 100mg R:
PO D: q24
O:
Unknown
P: 2-4hr
D:
Unknown
Max 10mg
Daily
D: 1-2mg
depending on
CIWA R: PO or
IV F:q4 PRN
O:1hr P:
2hr D:
12-24hr
0900
0900
q4 PRN
with
CIWA
score
Analgesia,
an -inflammatory effect
by inhibi ng
prostaglandin and other
substances that sensi ze
pain receptors,
fever-hypothalamic temp
regula ng center
an parkinsonian effect
by causing the release of
dopamine in the
substan a nigra. May
prevent release of viral
nucleic acid into the host
Poten ates the effects of
Resp failure, resp
GABA, Depresses the
depression, hypotension,
CNS, and suppresses the
seda on
spread of seizure ac vity
Monitor Hepa c, renal,
and hematopie c
func on
Anxiety, Withdrawal,
Insomnia, Pre-op
seda on